Rescate con Sirolimus por rechazo agudo recurrente y diabetes mellitus en trasplante hepático: Caso clínico pediátrico

Sirolimus (SRL) is a new immunosuppressive drug approved for renal transplantation, but is being used increasingly in orthotopic liver transplantation (OLT). Compared with the calcineurin inhibitors, SRL has different mechanisms of action and side effects profile. Thus, this drug offers significant...

Full description

Saved in:
Bibliographic Details
Main Authors: Roque E,Jorge, Ríos M,Gloria, Hepp K,Juan, Humeres A,Roberto, Ríos R,Horacio, Herrera,José M, Rius A,Montserrat
Language:Spanish / Castilian
Published: Sociedad Médica de Santiago 2005
Subjects:
Online Access:http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872005001000011
Tags: Add Tag
No Tags, Be the first to tag this record!